Parvovirus B19 and the kidney.

Area of Science:

• Nephrology
• Virology
• Immunology

Background:

• Parvovirus B19 causes various clinical syndromes.
• B19 infection is associated with renal disease, including glomerulopathy and anemia in end-stage renal disease (ESRD) and kidney transplant patients.
• Case reports suggest B19's role in proliferative glomerulonephritis and collapsing glomerulopathy.

Purpose of the Study:

• To explore the link between parvovirus B19 infection and kidney disease.
• To investigate the mechanisms by which B19 may affect the kidneys.
• To highlight the clinical significance of B19 in dialysis and transplant populations.

Main Methods:

• Review of case reports and existing literature.
• Analysis of proposed pathogenetic mechanisms, including cytopathic effects and immune complex deposition.
• Evaluation of B19's impact on anemia and graft outcomes in renal patients.

Main Results:

• B19 infection is associated with acute glomerulopathy and anemia in ESRD and transplant patients.
• Potential mechanisms include direct viral effects on glomerular cells and immune-mediated damage.
• Dialysis patients and transplant recipients may be more susceptible to B19-related anemia and complications.
• Chronic anemia and pure red cell aplasia are common in transplant recipients with B19 infection.
• Allograft rejection and dysfunction have been reported but require further investigation.

Conclusions:

• Parvovirus B19 infection is implicated in various renal syndromes, particularly in vulnerable populations like dialysis and transplant patients.
• The diagnosis of B19 infection should be considered in transplant recipients with unexplained anemia or pancytopenia.
• Further research is warranted to establish causal relationships and elucidate the pathogenesis of B19-related kidney disease.